<SEC-DOCUMENT>0001144204-15-013929.txt : 20150304
<SEC-HEADER>0001144204-15-013929.hdr.sgml : 20150304
<ACCEPTANCE-DATETIME>20150304160616
ACCESSION NUMBER:		0001144204-15-013929
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20150304
DATE AS OF CHANGE:		20150304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ruthigen, Inc.
		CENTRAL INDEX KEY:			0001574235
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				461821392
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-190476
		FILM NUMBER:		15673439

	BUSINESS ADDRESS:	
		STREET 1:		2455 BENNETT VALLEY RD. SUITE C116
		CITY:			SANTA ROSA
		STATE:			CA
		ZIP:			95404
		BUSINESS PHONE:		(707) 525-9900

	MAIL ADDRESS:	
		STREET 1:		2455 BENNETT VALLEY RD. SUITE C116
		CITY:			SANTA ROSA
		STATE:			CA
		ZIP:			95404
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>v403612_424b3.htm
<DESCRIPTION>FORM 424B3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule 424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-190476</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS SUPPLEMENT NO. 6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>To Prospectus dated August 12, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 97.5pt; width: 189pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(i) 3,047,500 Shares of Common Stock
and 3,047,500 Series B Warrants, issuable upon the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>exercise of the 3,047,500 outstanding
Series A Warrants issued in our Initial Public Offering</B><BR>
<B>and</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(ii) 3,047,500 Shares of Common Stock,
issuable upon the exercise of the 3,047,500 Series B Warrants </B><BR>
<B>that are issuable under this Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>_______________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement No. 6 supplements
the prospectus dated August 12, 2014, as supplemented by prospectus supplement No. 1 dated August 14, 2014, prospectus supplement
No. 2 dated November 17, 2014, prospectus supplement No. 3 dated November 28, 2014, prospectus supplement No. 4 dated January 20,
2015 and prospectus supplement No.5 dated February 19, 2015 (collectively, the &ldquo;prospectus&rdquo;), which relates to the
offering of the securities of Ruthigen, Inc. (the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;)
that are underlying the Series A Warrants that we issued in our initial public offering, which closed on March 26, 2014 (&ldquo;IPO&rdquo;).
The securities underlying the Series A Warrants include (i) 3,047,500 shares of our common stock and 3,047,500 of our Series B
Warrants, which are issuable upon the exercise of the 3,047,500 outstanding Series A Warrants that we issued in our IPO, and (ii)
3,047,500 shares of our common stock, which are issuable upon the exercise of the 3,047,500 Series B Warrants that are issuable
under the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each outstanding Series A Warrant is exercisable
for one share of common stock and one Series B Warrant. The Series A Warrants are exercisable at an initial exercise price of $7.25
per warrant and expire in March 2016. The Series B Warrants will only be issued upon the exercise of the Series A Warrants. Each
Series B Warrant is exercisable for one share of common stock. The Series B Warrants are immediately exercisable upon issuance
at an initial exercise price of $9.0625 per warrant. The Series B Warrants will expire on the fifth anniversary of the date of
issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement incorporates
into our prospectus the information contained in our attached current report on Form 8-K, which was filed with the Securities and
Exchange Commission on March 2, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should read this prospectus supplement
in conjunction with the prospectus, including any supplements and amendments thereto. This prospectus supplement is qualified by
reference to the prospectus except to the extent that the information in this prospectus supplement supersedes the information
contained in the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement is not complete
without, and may not be delivered or utilized except in connection with, the prospectus, including any supplements and amendments
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock is traded on The NASDAQ
Capital Market under the symbol &ldquo;RTGN.&rdquo; On March 3, 2015, the closing sale price of our common stock on The NASDAQ
Capital Market was $3.87 per share.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&#9;_______________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AN INVESTMENT IN OUR SECURITIES INVOLVES
RISKS. SEE THE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECTION ENTITLED &ldquo;RISK FACTORS&rdquo;
BEGINNING ON PAGE 9 OF THE PROSPECTUS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>_______________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Neither the Securities and Exchange Commission
nor any state securities commission has </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>approved or disapproved of these securities
or determined if this prospectus is truthful </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>or complete. Any representation to the
contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>_______________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The date of this prospectus supplement is
March 4, 2015</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
February 27, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RUTHIGEN, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;(Exact name of
registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Delaware</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">001-36199</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">46-1821392</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of incorporation)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(IRS Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 66%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2455 Bennett Valley Road, Suite C116</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Santa Rosa, California</P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">95404</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code <U>(707) 525-9900</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">__________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section 5 - Corporate Governance and Management</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.02 Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective February 27, 2015, Akihisa Akao
was appointed a Class II director of Ruthigen, Inc. (the &ldquo;Company&rdquo;) and as a member of the Company&rsquo;s Audit Committee.
Also effective February 27, 2015, Hojabr Alimi, the Company&rsquo;s Chief Executive Officer, resigned as a member of the Company&rsquo;s
Audit Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Akihisa Akao, </I>60, has been the Chief
Executive Officer of White Moon Medical, Inc. since he founded such company in 1999. The company provides consulting services as
well as capital to early-stage healthcare companies who are expanding into Asian markets. Mr. Akao served as a director of Oculus
Innovative Sciences, Inc. from April 1999 until May 2008. Mr. Akao has 38 years of experience in the healthcare industry and development
therapies in areas of pulmonology, wound care, general surgery, cardiovascular and anesthesiology. Mr. Akao has served on the board
of directors at MedTech Heart K.K., a medical technology company, since August 2011. He has served as the general manager in Japan
at Power Medical Interventions Inc., a medical device company, from January 2001 to September 2005 and as President from December
2006 to December 2009 until its merger with Covidien. Mr. Akao received a B.A. in electronic engineering from Doshisha University,
Kyoto Japan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no arrangement or understanding
between Mr. Akao and any other persons pursuant to which Mr. Akao was selected as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is currently no arrangement or agreement
regarding the compensation of Mr. Akao with respect to serving as a director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date:&nbsp;&nbsp;March 2, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">RUTHIGEN, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 48%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD NOWRAP><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Hojabr Alimi</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD NOWRAP><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Hojabr Alimi</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD NOWRAP><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^(,6$E#
M0U]04D]&24Q%``$!```,2$QI;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`
M,0``86-S<$U31E0`````245#('-21T(``````````````````/;6``$`````
MTRU(4"`@````````````````````````````````````````````````````
M```````````18W!R=````5`````S9&5S8P```80```!L=W1P=````?`````4
M8FMP=````@0````4<EA96@```A@````49UA96@```BP````48EA96@```D``
M```49&UN9````E0```!P9&UD9````L0```"(=G5E9````TP```"&=FEE=P``
M`]0````D;'5M:0```_@````4;65A<P``!`P````D=&5C:```!#`````,<E12
M0P``!#P```@,9U120P``!#P```@,8E120P``!#P```@,=&5X=`````!#;W!Y
M<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`
M````````$G-21T(@245#-C$Y-C8M,BXQ```````````````2<U)'0B!)14,V
M,3DV-BTR+C$`````````````````````````````````````````````````
M`````````````````%A96B````````#S40`!`````1;,6%E:(```````````
M``````````!865H@````````;Z(``#CU```#D%A96B````````!BF0``MX4`
M`!C:6%E:(````````"2@```/A```ML]D97-C`````````!9)14,@:'1T<#HO
M+W=W=RYI96,N8V@``````````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`
M````````````````````````````````````````````````````````````
M9&5S8P`````````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@
M<W!A8V4@+2!S4D="```````````````N245#(#8Q.38V+3(N,2!$969A=6QT
M(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="````````````````````````````
M`&1E<V,`````````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)
M14,V,3DV-BTR+C$``````````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD
M:71I;VX@:6X@245#-C$Y-C8M,BXQ````````````````````````````````
M``!V:65W```````3I/X`%%\N`!#/%``#[<P`!!,+``-<G@````%865H@````
M``!,"58`4````%<?YVUE87,``````````0````````````````````````*/
M`````G-I9R``````0U)4(&-U<G8````````$``````4`"@`/`!0`&0`>`",`
M*``M`#(`-P`[`$``10!*`$\`5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5
M`)H`GP"D`*D`K@"R`+<`O`#!`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!
M#0$3`1D!'P$E`2L!,@$X`3X!10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A
M`:D!L0&Y`<$!R0'1`=D!X0'I`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"
M9P)Q`GH"A`*.`I@"H@*L`K8"P0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/
M`UH#9@-R`WX#B@.6`Z(#K@.Z`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$
M<01^!(P$F@2H!+8$Q`33!.$$\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U
M!<4%U07E!?8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'
M/0=/!V$'=`>&!YD'K`>_!]('Y0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG
M"/L)$`DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*
MW`KS"PL+(@LY"U$+:0N`"Y@+L`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS
M#0T-)@U`#5H-=`V.#:D-PPW>#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/
M7@]Z#Y8/LP_/#^P0"1`F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H
M$@<2)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4
MSA3P%1(5-!56%7@5FQ6]%>`6`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2
M%_<8&QA`&&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;
M.QMC&XH;LAO:'`(<*AQ2''L<HQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^
M'ND?$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(B
MKR+=(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W
M)N@G&"=))WHGJR?<*`TH/RAQ**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K
M-BMI*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'
M+_XP-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XT
MV#43-4TUAS7"-?TV-S9R-JXVZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY
M.C8Z=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_
MHC_B0"-`9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D55
M19I%WD8B1F=&JT;P1S5'>T?`2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+
MFDOB3"I,<DRZ30)-2DV33=Q.)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F
M4C%2?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8
MRUD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S
M8`5@5V"J8/QA3V&B8?5B26*<8O!C0V.78^MD0&249.EE/6629>=F/6:29NAG
M/6>39^EH/VB6:.QI0VF::?%J2&J?:O=K3VNG:_]L5VRO;0AM8&VY;A)N:V[$
M;QYO>&_1<"MPAG#@<3IQE7'P<DMRIG,!<UUSN'04='!TS'4H=85UX78^=IMV
M^'=6=[-X$7AN>,QY*GF)>>=Z1GJE>P1[8WO"?"%\@7SA?4%]H7X!?F)^PG\C
M?X1_Y8!'@*B!"H%K@<V",(*2@O2#5X.ZA!V$@(3CA4>%JX8.AG*&UX<[AY^(
M!(AIB,Z),XF9B?Z*9(K*BS"+EHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6
MD3^1J)(1DGJ2XY--D[:4()2*E/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R:
M:)K5FT*;KYP<G(F<]YUDG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/F
MI%:DQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN
M+:ZAKQ:OB[``L'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9
MN-&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#
M6,/4Q%'$SL5+Q<C&1L;#QT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XV
MSK;/-\^XT#G0NM$\T;[2/]+!TT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9
M\=IVVOO;@-P%W(K=$-V6WAS>HM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$
MY@WFEN<?YZGH,NB\Z4;IT.I;ZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q
M__*,\QGSI_0T],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+
M_MS_;?___^X`#D%D;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&
M!@@+#`H*"PH*#!`,#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?
M'P$'!P<-#`T8$!`8&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?_\``$0@`@@#\`P$1``(1`0,1`?_$`)H`
M`0`"`P$!`0`````````````'"`4&"00#`@$!`````````````````````!``
M``4!`@4*$`D'"0D```````$"`P0%$0825@<(&"$Q,M(3DS24-A=!43.STQ14
MU.0U=96E%F8W82)28K)C<W2T<4(CA!6U1H'!T<)#Q89'EY%R@E-$9%6%5Q$!
M`````````````````````/_:``P#`0`"$0,1`#\`@>]%_K]M7FJ[;=XZHAM$
MV0E"$S9!))).J(B(B7J$0#&<X5_L9:KQZ3MP#G"O]C+5>/2=N`<X5_L9:KQZ
M3MP#G"O]C+5>/2=N`<X5_L9:KQZ3MP#G"O\`8RU7CTG;@'.%?[&6J\>D[<`Y
MPK_8RU7CTG;@'.%?[&6J\>D[<`YPK_8RU7CTG;@'.%?[&6J\>D[<!9',RO'>
M&L5.]*:M5)=12RS#-E,M]U\D&I;MIIW12K+;.@`Q>>+>>\M(OS16:55IM/9<
MIA+<:BR'64J5VPZ6$:6U)(SL+7`0%SA7^QEJO'I.W`.<*_V,M5X])VX!SA7^
MQEJO'I.W`.<*_P!C+5>/2=N`<X5_L9:KQZ3MP#G"O]C+5>/2=N`<X5_L9:KQ
MZ3MP#G"O]C+5>/2=N`<X5_L9:KQZ3MP#G"O]C+5>/2=N`<X5_L9:KQZ3MP%Y
M\VNHU"HY%+N3*A)=F3'>W=UDR%J=<5@SWTIPEK,U'8DB(O@`2:`YE\X5_L9:
MKQZ3MP#G"O\`8RU7CTG;@'.%?[&6J\>D[<`YPK_8RU7CTG;@'.%?[&6J\>D[
M<!Y+V<J:S]^D]>4`Q0```,O3[GWMJ45,NG42?-B+,R1(CQ7G6S-)V&1+0E23
ML,!Z>;V_V+55XC)V@#XR+E7QC<)H-19M*W])$?1J%T=5!`,0ZTZTLVW4*;<3
MLD*(R,ORD8#\`````+09CGC6]WV$+Z;P#$Y[7+ZA>2B_$N@*Z@``````````
M```"_P#FN>XF[/Z]^\)`"50'*L``````96]G*FL_?I/7E`,4```"^N:?[DJ1
M]O,_$K`:UG$Y:,IMQKV0Z7=B&RY3)%/:D.2G8KCYID+??0I)+)1(V#23P3(!
M'MWLY_+_`"Y;4>/=UBLKM)*F6Z?*-Q5I_4K*P]34U+/@`6C=H='O;=F&N^%`
MC;K)BMN3*=,2W([6<6@E.-DZ9:[:K2PDV=,!SNO_`$^[U.OM6X-W'^V:'&F.
MMT]\E;H1M)585B_SR+6)71+5`:^```"T&8YXUO=]A"^F\`Q.>UR^H7DHOQ+H
M"NH``````````````O\`YKGN)NS^O?O"0`E4!RK``````&5O9RIK/WZ3UY0#
M%````OKFG^Y*D?;S/Q*P&M9PN<+?3)Q?2%0Z'"ILF))IK4U:YK3ZW"<6^^T9
M$;3[*<'!9+H=/5`:Q<+/1GR:S%A7SI,2/`DN):<J4`W6R8PU6$XMIU3V$A-O
MQK%6V:NKK`)ZRC9,*+?RCO4^?.J$/=4&E"X<M]MJTRL(UQL/<'"_WD?RD`YS
M52`[3JG+I[VJ]#><CN'99\9I9H/4/X2`>4```%H,QSQK>[["%]-X!B<]KE]0
MO)1?B70%=0`````````````!?_-<]Q-V?U[]X2`$J@.58``````RM[.5-9^_
M2>O*`8H```$J7#SD,H5R+M1[NT9N`JGQE.+;.0PM;EKJS<5:I+B"UU=(!J^4
MG*7>+*'76*U7TQTS(\5$)LHJ%-HW)#CCI6DI2]7">5T0&I@)OA9W^5F)#8B(
M;IBT1VT-)6Y'<4M1(222-1[L5IG9J@(BO'7)->KT^MRFFF)52?7*D-QTJ2UN
MKJL)9I2I2S+"49G9:`QH```+09CGC6]WV$+Z;P#$Y[7+ZA>2B_$N@*Z@````
M`````````"_^:Y[B;L_KW[PD`)5`<JP`````!E;V<J:S]^D]>4`Q0```````
M```````M!F.>-;W?80OIO`,3GM<OJ%Y*+\2Z`KJ``````````````+_YKGN)
MNS^O?O"0`E4!RK``````&YWHN56'+S5=Q,BEDE<V0HB55Z6E5ANJ/52J21D?
MP&`QGJ/6NZ:5YXI7?(!ZCUKNFE>>*5WR`>H]:[II7GBE=\@'J/6NZ:5YXI7?
M(!ZCUKNFE>>*5WR`>H]:[II7GBE=\@'J/6NZ:5YXI7?(!ZCUKNFE>>*5WR`>
MH]:[II7GBE=\@'J/6NZ:5YXI7?(!ZCUKNFE>>*5WR`GC-5JE"N+4+Q.WJK=*
MIS<]J*B(K]I0G\,VE.&LOT#SMEF&6N`Q^='*I-^+WTFH77K%*J$.-3RCON_M
M*"Q@N;LXO!P7WFE'\51:I%8`A?U'K7=-*\\4KOD`]1ZUW32O/%*[Y`/4>M=T
MTKSQ2N^0#U'K7=-*\\4KOD`]1ZUW32O/%*[Y`/4>M=TTKSQ2N^0&QT#(!E6O
M%!.?0J2Q4X1+-HY$:HTUQ&&DB-2<),FRTB40#7/4>M=TTKSQ2N^0#U'K7=-*
M\\4KOD`]1ZUW32O/%*[Y`/4>M=TTKSQ2N^0%O\@F4*X%U<D]"H->O+2H=6A]
MM=LQNWHSN#NLQYU'QVEK0=J%I/44`D#GKR1XWTKC37]("@'J/6NZ:5YXI7?(
M!ZCUKNFE>>*5WR`>H]:[II7GBE=\@'J/6NZ:5YXI7?(!ZCUKNFE>>*5WR`\E
M[.5-9^_2>O*`8H````````````````````````!>#,V]T;WE63UID!1\````
M``````````96]G*FL_?I/7E`,4`````````````````````````O!F;>Z-[R
MK)ZTR`H^``````````````);O%F[Y9I5X*G)CW8?<8?EON-+)Z,1*0MQ2DGJ
MN]$C`8_1NRVXK/[]&[*`:-V6W%9_?HW90#1NRVXK/[]&[*`:-V6W%9_?HW90
M#1NRVXK/[]&[*`:-V6W%9_?HW90#1NRVXK/[]&[*`:-V6W%9_?HW90#1NRVX
MK/[]&[*`:-V6W%9_?HW90#1NRVXK/[]&[*`:-V6W%9_?HW90#1NRVXK/[]&[
M*`:-V6W%9_?HW90#1NRVXK/[]&[*`:-V6W%9_?HW90#1NRVXK/[]&[*`:-V6
MW%9_?HW90#1NRVXK/[]&[*`M=FQ7-O+=')N[2KQ054^H*J+[Y,+4A9[FMMHD
MJM;4LM4TGT0%!@`````````````!<FIYZ%V(%2EP5W<FK7$><84LGFB(S;6:
M3,ORV`/-IO76Q:G;\R`:;UUL6IV_,@&F]=;%J=OS(!IO76Q:G;\R`:;UUL6I
MV_,@&F]=;%J=OS(!IO76Q:G;\R`:;UUL6IV_,@&F]=;%J=OS(!IO76Q:G;\R
M`:;UUL6IV_,@&F]=;%J=OS(!IO76Q:G;\R`:;UUL6IV_,@&F]=;%J=OS(!IO
M76Q:G;\R`:;UUL6IV_,@&F]=;%J=OS(!IO76Q:G;\R`F')/E,@Y1KKKO!"A.
MP&427(NX/*2M6$VE"C5:G4L/#`<W@`````````````!E;V<J:S]^D]>4`Q0`
M```````````````````````"\&9M[HWO*LGK3("CX``````````````RM[.5
M-9^_2>O*`8H````````````````````````!>#,V]T;WE63UID!1\```````
M```````69KV;#<B17*A(D95*9$?>DO..Q7&8^&TI;AJ-"K9R3M29V:Q`/DC-
M'NFM"5HRHP%(41&E1163(R/6,C[>`>N%F84F<=D+*''E&5I?H8"'-4M4]C-/
MI@/7H,>VWHOPP`T&/;;T7X8`:#'MMZ+\,`-!CVV]%^&`&@Q[;>B_#`#08]MO
M1?A@!H,>VWHOPP`T&/;;T7X8`:#'MMZ+\,`-!CVV]%^&`&@Q[;>B_#`#08]M
MO1?A@!H,>VWHOPP`T&/;;T7X8`:#'MMZ+\,`-!CVV]%^&`&@Q[;>B_#`$UY(
M\G,;);<U="D5A$]M4MV5VZXT41)&XA!8&";CNMN=MN$`@B'F8T><>#"RB1Y2
MM:QF`AP[2*W\V:8#V:#'MMZ+\,`-!CVV]%^&`&@Q[;>B_#`#08]MO1?A@!H,
M>VWHOPP`/,9(BM.^UA%KG^R_#`'G:S*:>ZLFVLH#+CBMBA-/29G^0BF`/1H,
M>VWHOPP!\G\R*+'(C?OXADE;$W*:2;;.E;,`?C0JIVY[IS@,[G;@X?[/3@X5
MEMEO;FN`K[E"Y?7E\JSOQ*P%C;I9,<U*9=F`_4Z_"15'H<=<Y+U80PMM];1&
MZ24&M&LNW4L.P!&>6RZ^0NA18CV3R\+TZL&^DGX:'.V8Z&229[JE\D)P5DLB
MU,-6OK$`F/,_J64Z;$JAU]R9(NH337[*?GFM1[M;JIC*<^,IK<]E8>"1V6:Y
M@,CGJ^ZRE>7(_P"#E@,5F0\EKR_?F>L@+*`*`9T?OVO-^H_N^.`N=*NA3;X9
M+(MVJFZ\S!J-.B(?<C*0ETB0EMPL`UI<26J@M=)@(DKF9ODQ@46H3F:G6U.Q
M(SS[:5OQ#2:FVS41*LBD=EI=,!3<!<Z#F89+GX4=]=4K9+=;0M1$_$LM4DC.
MRV*`D2]-UZ?=7(->&[M/<==A4V[M188<D&E3II*(Z=JS0E"3/5Z"2`4PS?[R
M42[65R@UNN2DPJ7$[;[8E+)2B1ND)YI%I()2M5:R+4(!<?21R)8TL;S)[$`K
M3G77_N??*\-"DW9J2*DQ$B.M2%H0X@DK4[A$1[HE'0`39F;>Z-[RK)ZTR`BG
M/:Y?4+R47XET!,&:%[FXWWZ7](@&I9S&</7+MU=RY5TG>U*@TVA=6JA$1N-F
M\@EH99MU$JW-1*4O7U2LL,!B\FV:X_?*C0[V91:[/D2*HTF5'AMNX3Q-.EAH
M4\^^3QVK29*P"25G1.W4(,O>+-7R-DRZU2;T.T>L,:C:I$R.ZA#J"L_2-&3;
MEMI6ZBRL`?K(A3\M5VJ^S3JS>BD5*[)N[@N%*J:93ZDVX"%0C23KB3UC2VHT
MD>L9$>J062`<O[K0J3/O/2(-8D'#I$J;&8J,LE)0;49QU*7G"6LE)3@(,SM,
MC(@%C.97-0_^B/\`G*G][`/=0\@^;).K$.+2K]2IE1<=3VK%;J$!:W%I/"))
M)3&M/6`6<JWBJ;]@[]`P',ZZ%&O!6;R0:?=TE'7'%*<I^YKW)S=6$*>+`7:G
M!7^C^+JEJ@+79$\YE4J4BYV4@SIMX&%=KLU20G<4NN)/!W*4E6#N3W0PK"2K
MHV'L@^&>]R6NU]^>ZR`K_P#Y!?XJ_NX!K^4+E]>7RK._$K`7/NAF\9&JG<NA
MRYMVFG9,RG1'I+Q/RD*4XXRA:U6H=39:H^@`@'.0R*TW)K4J55[LOO-TFI*6
ME#+CAJ=C2&;%%@.:BC2I*K4VF9D9'JZP"7\T3*9>6]5(K='O#47*C(I"H[D)
M^0>&^;+Y.)4E3AGA.8"FBU5:OQM?I!GL["Z%X+S9+VVJ'$7.D4VHLSWXS1&I
MU3"&'FEFV@M59I-XCL+5LM`09FU9;;LY.4U>BWH8DL,SWT.IF-(W3<G&TFA:
M'6M19?E21G;T`$]R\Z_(BQ&)UJLO2G,&WM=J'*)=OR;76VT6_P#%8`JA?.36
M\L65FJ52ZM'DO+JKK*6(I)PE-M-,MQT./K3:ALC)K"49JP2Z8#H!1(3D"C0(
M+IDIR+&986I.L:FVR29E_L`>>]G)6L_<9/65`.8`#J52?%4+[!KZ!`-?RL>Z
MR^7D.I?@W`%'<W6B4BMY8[OTNL0VI].D=N;O$D()QM>!!?6G"2>H=BTD9?"`
MNOS*9(\4*5Q5K^@!5[.[NA=>[5X[OL7?I4:ELR(;JWVXK:6DK43MA&HDD5IV
M`)BS-O=&]Y5D]:9`13GM<OJ%Y*+\2Z`F#-"]S<;[]+^D0"+LZ?(A>IV]DJ_-
M!AN5*FU!#9U)B,DUO1W66R:-9MIM4IM2&R4:BUCMMLU#,-@R0YV5TX=V*?0;
MZ(D0)],91$*H-M&^RZVRDD(4M+=KJ%X)$2BP3(]>W5L`:W?VKYHM0J%2O"J3
M5*S5Z@ZY)=CPRDL$IYPS4>K);90E-OPG9\("'<FZHZ\L5U5QHZHD9=X*>N/%
M4HUJ;;5-;-"#6HB-5B3+XW1`=(0',*Z#U%8O91'ZZ@G*(U/BKJJ#2:R5%2\D
MWR-*?C*M;PM0@%GO7+,M_P#%,<1F;4![*/E*S0*-4X]4I<-N)4(B]TC26X,L
MEH66I:5J0$^HJT&L7335X"S<@U&`4N(X:32:FGV=T;,TJL,K4J+4,!0S-N]]
MMUOMWOPSH"VF6G(!=O*-$5,9P*9>AE-D>J)3\5TB+4;DI3LT])6R3T-34,*B
M92ZEE.I5,AY/+[H7@T)XWJ8Z]:M>XJ1N9):>ML=9L+XGR=C\!!\_\@O\5?W<
M`M#6?&\[W9<(=X9PG9GU?ZSY?P@)GHWBB#P?@[7`^#;`NH?5_(^`!K&5+Q1$
MY.<(_BG@VP5U+ZS^:T!A,EWCV3R+X*KDOPOJB.J?5=/YV"`DX!$&6#AI>[_H
M<L.J]`!#U$X:Y[G];_J]ALBV'SND`LWD_P"3Z/$VR_A_@6L6Q^$!LH#SU'Q?
M)ZEU)?".H[$^J_,^5\`""/\`2H!/<?@[6PV">I[#6_-^;T@'CO#X@J?!."/^
M,>!]35PGZG_F?-M`1A<+E9!]W_\`:^(/&745]0_K_,P@$O@(XRI^,(/(_J2N
M575ME_8?,Z?P@,YDTY.J\1<(7R9X#L4Z_P!9\KX+`&OY4O&\3D;P?^*>$[-7
M4OJ_Y[0&QY..3*/$G57.3G`-?\WY_P`H!M`"#<LO#Y'NZV*N4_#MBK8_/Z0#
M5LF/C1GW5[,^`^,==/4_F_S@)$G>\5/(7Q@SU?QYLTZW_<_(^=8`E<!`'^E0
M!_I4`?Z5`)KHW)B#P+@37`_%_4BZA]1\CYH",+D\J8'N]V:O$GC#8*X/\[I_
I-M`3&`T'*KL*=R5UW>56M^;P;^O_`"`-6_A#_+KQA_ZSJ/XG^H`__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
